La Jolla, CA – February 23, 2024 – Dr. Abdulkader Rahmo, President and Chief Scientific Officer at SMSbiotech, will be in attendance at the esteemed Biocom Global Life Science Partnering & Investor Conference, scheduled for February 27th in La Jolla, California. This prestigious event serves as a powerful platform, bringing together the brightest minds in the industry – experts, thought leaders, and innovators – to spark groundbreaking conversations and fuel the future of life sciences.
Dr. Rahmo's participation underscores his commitment to staying at the forefront of this dynamic field. The Biocom Conference offers a unique opportunity to delve into current trends, exchange groundbreaking research findings, and explore potential collaborations with other industry pioneers. Dr. Rahmo is eager to gain valuable insights, connect with fellow professionals, and foster collaborations that hold immense potential for advancing scientific progress and improving human health.
About the Biocom Global Life Science Partnering & Investor Conference:
The Biocom Conference is a premier gathering for the life sciences community, attracting over 1,000 attendees from across the globe. It serves as a key platform for facilitating one-on-one partnering meetings, fostering meaningful connections, and driving innovation within the industry. The event features thought-provoking panel discussions, fireside chats with industry luminaries, and presentations from emerging companies seeking funding and partnerships.
Contact:
For more information about the Biocom Global Life Science Partnering & Investor Conference or to arrange a meeting with Dr. Rahmo, please contact a.rahmo@smsbiotech.com.
